Whole body MRI
Whole body MRI is a medical device with 17 clinical trials. Currently 5 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
3
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
5
trials recruiting
17
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Bone Arches: Performance of Pseudo-scanner Sequences in Segmenting the Extent of the Tumour and in Planning Surgical Resection Using the CT Scan as a Reference
The Synergistic Effects of Menopause and HIV on Cardiovascular Disease Risk in Women
Occupational Cancer Screening in Firefighters: A Pilot Study Within the Inova Health System
Screening With Whole Body MRI For Detection Of Primary Tumors In Children And Adults With Li-Fraumeni Syndrome (LFS) And Other Cancer Predisposition Syndromes
Whole Body MRI for Non-invasive Lesion Detection and Therapy Follow-up: Study With Patients With Radiographic axSpA and Non-radiographic axSpA
Clinical Trials (17)
Bone Arches: Performance of Pseudo-scanner Sequences in Segmenting the Extent of the Tumour and in Planning Surgical Resection Using the CT Scan as a Reference
The Synergistic Effects of Menopause and HIV on Cardiovascular Disease Risk in Women
Occupational Cancer Screening in Firefighters: A Pilot Study Within the Inova Health System
Screening With Whole Body MRI For Detection Of Primary Tumors In Children And Adults With Li-Fraumeni Syndrome (LFS) And Other Cancer Predisposition Syndromes
Whole Body MRI for Non-invasive Lesion Detection and Therapy Follow-up: Study With Patients With Radiographic axSpA and Non-radiographic axSpA
Dual-Energy Computed Tomography for Improving Imaging Assessment of Multiple Myeloma
Imaging Staging and Response Prediction in Metastatic Hormono-Sensitive Prostate Cancer Patients Receiving Enzalutamide
PET/CT and WB MRI for Staging and Response in CRPC Patients Receiving Enzalutamide
Magnetic Resonance Imaging Screening in Li Fraumeni Syndrome
Whole Body MRI to Identify Atypical Neurofibromas in Patients With NF1
LIFSCREEN : Evaluation of Whole Body MRI for Early Detection of Cancers in Subjects With P53 Mutation (Li-Fraumeni Syndrome)
Magnetic Resonance Imaging of the Whole Body, Including Diffusion, in the Medical Evaluation of Breast Cancers at High Risk for Metastasis and the Follow-up of Metastatic Cancers
FOcal RECurrent Assessment and Salvage Treatment
18F-FCH (Fluorocholine)-PET/MR in Staging of High-Risk Prostate Cancer
Whole Body Magnetic Resonance Imaging (MRI) for Detection of Cancer Metastases
Localising Occult Prostate Cancer Metastases With Advanced Imaging TEchniques
Whole Body PET-MRI in Paediatric and Adolescent Lymphoma
All 17 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 17